183 related articles for article (PubMed ID: 36759514)
41. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
[TBL] [Abstract][Full Text] [Related]
42. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
43. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
[TBL] [Abstract][Full Text] [Related]
44. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
45. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
46. Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
Stachler MD; Camarda ND; Deitrick C; Kim A; Agoston AT; Odze RD; Hornick JL; Nag A; Thorner AR; Ducar M; Noffsinger A; Lash RH; Redston M; Carter SL; Davison JM; Bass AJ
Gastroenterology; 2018 Jul; 155(1):156-167. PubMed ID: 29608884
[TBL] [Abstract][Full Text] [Related]
47. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
[TBL] [Abstract][Full Text] [Related]
48. Genomic instability signals offer diagnostic possibility in early cancer detection.
Killcoyne S; Yusuf A; Fitzgerald RC
Trends Genet; 2021 Nov; 37(11):966-972. PubMed ID: 34218956
[TBL] [Abstract][Full Text] [Related]
49. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
[TBL] [Abstract][Full Text] [Related]
50. Identification and clinical implementation of biomarkers for Barrett's esophagus.
Varghese S; Lao-Sirieix P; Fitzgerald RC
Gastroenterology; 2012 Mar; 142(3):435-441.e2. PubMed ID: 22266150
[No Abstract] [Full Text] [Related]
51. Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
Saad R; Chen Z; Zhu S; Jia P; Zhao Z; Washington MK; Belkhiri A; El-Rifai W
PLoS One; 2013; 8(5):e64463. PubMed ID: 23724052
[TBL] [Abstract][Full Text] [Related]
52. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma.
Wang XW; Gao HJ; Fang DC
J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638
[TBL] [Abstract][Full Text] [Related]
53. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Kan T; Meltzer SJ
Curr Opin Pharmacol; 2009 Dec; 9(6):727-32. PubMed ID: 19773200
[TBL] [Abstract][Full Text] [Related]
54. Novel epigenetic network biomarkers for early detection of esophageal cancer.
Maity AK; Stone TC; Ward V; Webster AP; Yang Z; Hogan A; McBain H; Duku M; Ho KMA; Wolfson P; Graham DG; ; Beck S; Teschendorff AE; Lovat LB
Clin Epigenetics; 2022 Feb; 14(1):23. PubMed ID: 35164838
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
Gu J; Ajani JA; Hawk ET; Ye Y; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Wang KK; Wu X
Cancer Prev Res (Phila); 2010 Sep; 3(9):1176-86. PubMed ID: 20651033
[TBL] [Abstract][Full Text] [Related]
56. Role of Extracellular Vesicles in the Diagnosis and Pathogenesis of Barrett's Esophagus: A Mini-Review.
Zhang Q; Bansal A
Dig Dis Sci; 2021 Mar; 66(3):705-713. PubMed ID: 32277372
[TBL] [Abstract][Full Text] [Related]
57. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.
Whiteman DC; Appleyard M; Bahin FF; Bobryshev YV; Bourke MJ; Brown I; Chung A; Clouston A; Dickins E; Emery J; Eslick GD; Gordon LG; Grimpen F; Hebbard G; Holliday L; Hourigan LF; Kendall BJ; Lee EY; Levert-Mignon A; Lord RV; Lord SJ; Maule D; Moss A; Norton I; Olver I; Pavey D; Raftopoulos S; Rajendra S; Schoeman M; Singh R; Sitas F; Smithers BM; Taylor AC; Thomas ML; Thomson I; To H; von Dincklage J; Vuletich C; Watson DI; Yusoff IF
J Gastroenterol Hepatol; 2015 May; 30(5):804-20. PubMed ID: 25612140
[TBL] [Abstract][Full Text] [Related]
58. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ
Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225
[TBL] [Abstract][Full Text] [Related]
59. Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma risk.
Wanchai V; Jin J; Bircan E; Eng C; Orloff M
BMC Bioinformatics; 2019 Mar; 20(Suppl 2):98. PubMed ID: 30871476
[TBL] [Abstract][Full Text] [Related]
60. Age of diagnosis in familial Barrett's associated neoplasia.
Glamour BK; Alaber O; Cioffi G; Chandar AK; Barnholtz-Sloan J; Brock W; Falk GW; Canto MI; Wang JS; Iyer PG; Shaheen NJ; Grady WM; Abrams JA; Thota PN; Chak A; Blum AE
Fam Cancer; 2022 Jan; 21(1):115-120. PubMed ID: 33694069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
